BioTech, BioMed & BioPharma: European Health Policy Leaders Discuss Initiatives Addressing Societal Impact Of Pain

(Comment on this article at http://www.financialwire.net/2010/05/10/biotech-biomed-biopharma-european-health-policy-leaders-discuss-initiatives-addressing-societal-impact-of-pain/)

May 10, 2010 (FinancialWire) (Investrend Forums Syndicate) (Investrend Information Syndicate) -- Editor's note: For our readers with particular interest in the healthcare and medical industries, as relating to ETFs such as the Health Care Select Sector SPDR ETF XLV, the SPDR S&P International Health Care Sector ETF IRY the First Trust Health Care AlphaDEX Fund FXH and the WisdomTree International Health Care Fund ETF DBR, FinancialWire(tm) contributor, The Zangani Investor Community(tm), provides the following recap of recent, related news:

190 high-ranking decision makers from 28 European countries met at the EFICAe (R) Symposium in Brussels on May 4th and 5th in an unprecedented discussion on the societal impact of pain. When it comes to the treatment of pain, the European healthcare community lacks broad consensus, understanding as well as common and effective appraisal tools, but there is broad agreement that treated patients cost national governments, economies and societies less than untreated patients do. That consensus was one of the important outcomes of the work at the Brussels symposium.

The Symposium's second day saw a lively debate on the presentation and discussion of interesting projects initiated in many countries to investigate the economic factors related to the burden of pain on patients and the society and suggest future innovations. Unfortunately the knowledge gained and management instruments developed locally are still too rarely shared amongst health care authorities and stakeholders throughout Europe. Today this began to change.

The discussions also underlined the need for a multidisciplinary approach to pain, including rehabilitation, and the need for better practical education and training for health care professional - general practitioners in particular - to improve health system co-ordination in many countries. The need for common definitions, tools and other evaluation systems that improve multidisciplinary and multinational analysis and comparisons and exchange of best practices also emerged... (For a preferred introduction to Zangani, write to resources@investrend.com with "Zangani Introduction" in the subject line); (Read more of this article at http://www.zangani.com/node/5790); (See also: "European Health Policy Leaders Open To Dialog On Approches To The Societal Impact Of Pain" at http://www.zangani.com/node/5784).

Other Headlines:

Australian Scientists Propose A Potential New Treatment For Type 2 Diabetes (at http://www.zangani.com/node/5812)

How Nerve Cells Distinguish Odors (at http://www.zangani.com/node/5768)

Stem Cell Lines On Hold (at http://infoescrow.net/f/?u=http://www.zangani.com/node/5793)

[Source: The Zangani Investor Community(tm)]

The Zangani Investor Community(tm) provides investor relations and market visibility programs. For a preferred introduction to Zangani -- which always includes free, value-added services from Investrend, as well as preferred client rates for Zangani programs (when applicable) -- write to resources@investrend.com with "Zangani Introduction" in the subject line.

Also visit http://www.financialwire.net/?s=%22Zangani+Investor%22 for related FinancialWire(tm) futures and forex articles submitted by the The Zangani Investor Community(tm).

[ssryrsyr] [bsdarrgnmnt] [zngngnz] [hlthcrdp] [biomedphrm] [exctrdfnd] [cnfrncvntprsntn]

http://www.financialwire.net